January 20th, 2010

Effective December 23rd, 2009, Enantia entered into the capital of Janus Developments along with two additional investors: the pharmaceutical group Ferrer and the financial institution Caixa Manresa. Following Enantia’s strategy to be closer to the emerging biotech sector, we decided to tighten relations with the recently founded start-up Janus Developments by entering into its capital. More detailed information can be found in the article appeared in Diario Expansión on January 20th, 2010.